Telmisartan improves insulin sensitivity: A meta-analysis of randomized head-to-head trials

International Journal of Cardiology

Volumn 156, Issue 1, 2012, Pages 92-96

  Takagi, Hisato ^a   Umemoto, Takuya ^a  

^a SHIZUOKA MEDICAL CENTER   (Japan)

Author keywords

Insulin; Insulin sensitivity; Meta analysis; Randomized head to head trial; Telmisartan

Indexed keywords

AMLODIPINE; AZILSARTAN; CANDESARTAN; EPROSARTAN; HYDROCHLOROTHIAZIDE; INSULIN; IRBESARTAN; LOSARTAN; OLMESARTAN; ROSIGLITAZONE; ROSUVASTATIN; TELMISARTAN; VALSARTAN;

ADVERSE DRUG REACTION; COMPARATIVE STUDY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG BINDING; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEART FAILURE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE;

EID: 84858071961     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.11.070     Document Type: Article

References (34)

1. S. Yamagishi, K. Nakamura, and T. Matsui Potential utility of telmisartan, an angiotensin II type 1 receptor blocker with peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-modulating activity for the treatment of cardiometabolic disorders Curr Mol Med 7 2007 463 469 (Pubitemid 47244891)
2. T.W. Kurtz Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator Acta Diabetol 42 Suppl. 1 2005 S9 S16
3. S.C. Benson, H.A. Pershadsingh, and C.I. Ho Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002 (Pubitemid 38579904)
4. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity Circulation 109 2004 2054 2057 (Pubitemid 38620211)
5. T.W. Kurtz, and M. Pravenec Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system J Hypertens 22 2004 2253 2261 (Pubitemid 39625096)
6. R. Muniyappa, S. Lee, H. Chen, and M.J. Quon Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 2008 E15 E26
7. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
8. T.M. Wallace, J.C. Levy, and D.R. Matthews Use and abuse of HOMA modeling Diabetes Care 27 2004 1487 1495 (Pubitemid 38680001)
9. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410 (Pubitemid 32269192)
10. H. Yokoyama, M. Emoto, and S. Fujiwara Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose J Clin Endocrinol Metab 89 2004 1481 1484 (Pubitemid 38368454)
11. Y. Mori, T. Tanaka, K. Matsuura, J. Yokoyama, and K. Utsunomiya Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE) Adv Ther 28 2011 698 706
12. O. Bahadir, M. Uzunlulu, A. Oguz, and M.A. Bahadir Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome Hypertens Res 30 2007 49 53
13. M. Clodi, M. Resl, and D. Stelzeneder Interactions of glucose metabolism and chronic heart failure Exp Clin Endocrinol Diabetes 117 2009 99 106
14. D.A. de Luis, R. Conde, and M. González-Sagrado Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients Nutr Hosp 25 2010 275 279
15. G. Derosa, P.D. Ragonesi, A. Mugellini, L. Ciccarelli, and R. Fogari Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study Hypertens Res 27 2004 457 464 (Pubitemid 39157547)
16. G. Derosa, E. Fogari, and A. D'Angelo Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone J Clin Pharm Ther 32 2007 261 268 (Pubitemid 46699517)
17. R. Fogari, A. Zoppi, and I. Ferrari Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients Horm Metab Res 41 2009 893 898
18. E.F. Georgescu, R. Ionescu, M. Niculescu, L. Mogoanta, and L. Vancica Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis World J Gastroenterol 15 2009 942 954
19. S.J. Hong, S.C. Choi, C.M. Ahn, J.H. Park, J.S. Kim, and D.S. Lim Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients Heart 97 2011 1425 1432
20. Y. Ichikawa Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome Intern Med 46 2007 1331 1336 (Pubitemid 47455754)
21. S. Makita, A. Abiko, Y. Naganuma, Y. Moriai, and M. Nakamura Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance Metabolism 57 2008 1473 1478
22. J. Minami, S. Furukata, T. Ishimitsu, and H. Matsuoka Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension Int Heart J 50 2009 85 93
23. S. Nakayama, H. Watada, and T. Mita Comparison of effects of olmesartan and telmisartan on blood pressure and metabolic parameters in Japanese early-stage type-2 diabetics with hypertension Hypertens Res 31 2008 7 13 (Pubitemid 351325609)
24. R. Negro, G. Formoso, and H. Hassan The effects of irbesartan and telmisartan on metabolic parameters and blood pressure in obese, insulin resistant, hypertensive patients J Endocrinol Invest 29 2006 957 961 (Pubitemid 46344228)
25. N. Ozaki, Y. Nomura, H. Sobajima, K. Kondo, and Y. Oiso Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus Eur J Intern Med 21 2010 236 239
26. S. Perl, I. Schmölzer, and H. Sourij Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance Int J Cardiol 139 2010 289 296
27. C.V. Rizos, H.J. Milionis, and M.S. Kostapanos Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study Clin Ther 32 2010 492 505
28. H. Tomiyama, J. Yamada, Y. Koji, K. Shiina, M. Yoshida, and A. Yamashina Effect of telmisartan on forearm postischemic hyperemia and serum asymmetric dimethylarginine levels Am J Hypertens 20 2007 1305 1311 (Pubitemid 350151686)
29. C. Vitale, G. Mercuro, and C. Castiglioni Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome Cardiovasc Diabetol 4 2005 6
30. M. Watanabe, K. Inukai, and T. Sumita Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients Intern Med 49 2010 1843 1847
31. S. Yamada, N. Ano, and K. Toda Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro Hypertens Res 31 2008 601 606 (Pubitemid 351772849)
32. Y. Yano, S. Hoshide, and J. Ishikawa The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients Am J Hypertens 20 2007 565 572 (Pubitemid 46691290)
33. S. Yusuf, H.C. Diener, and R.L. Sacco Telmisartan to prevent recurrent stroke and cardiovascular events N Engl J Med 359 2008 1225 1237
34. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet 2008;372:1174-83. Erratum in: Lancet 2008;372:1384.